Results 261 to 270 of about 500,318 (318)
Human microbiota, blood group antigens, and disease. [PDF]
Ewald DR, Sumner SCJ.
europepmc +1 more source
A Half Century of Blood-Group Antigen Research. Some Personal Recollections.
Winifred M. Watkins
openalex +2 more sources
A GRP78 nanobody‐directed immunotoxin suppresses cancer progression and metastasis by enhancing antitumor immunity via STING pathway activation, offering a pan‐cancer‐targeted approach and immunotherapy combination strategy. Abstract The lack of targetable antigens poses a significant challenge in developing effective cancer‐targeted therapies.
Huifang Wang+16 more
wiley +1 more source
Histo-blood group antigens and rotavirus vaccine shedding in Nicaraguan infants. [PDF]
Bucardo F+6 more
europepmc +1 more source
USP42 is identified as a novel DUB of PPARγ in hepatocytes. USP42 mediated PPARγ deubiquitylation determines its transcriptional preference on proliferative and redox balance genes. USP42 knockdown exacerbates liver damage and delays regeneration. FGF2 is the upstream signal that initiates and activates the USP42‐PPARγ axis.
Nanfei Yang+16 more
wiley +1 more source
Low-Frequency Blood Group Antigens in Switzerland. [PDF]
Gassner C+32 more
europepmc +1 more source
Binding of Rabbit Hemorrhagic Disease Virus to Antigens of the ABH Histo-Blood Group Family
Nathalie Ruvoën‐Clouet+4 more
openalex +1 more source
Artesunate Inhibits Neointimal Hyperplasia by Promoting IRF4 Associated Macrophage Polarization
This study shows that macrophage interferon regulatory factor 4 (IRF4) improved arterial injury‐induced neointimal hyperplasia by promoting of M2 polarization via up‐regulating krüppel‐like factor 4 (KLF4) in rodent and nonhuman primate models. Notably, artesunate is identified as a potent inducer of IRF4 in macrophages, and proposed as a promising ...
Jinlin Miao+15 more
wiley +1 more source